Atlas Trials

Duration of IPV Priming and Antibody Decay

Clinical trial NCT03202719 · COMPLETED

Trial details

NCT number
NCT03202719
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Poliomyelitis
Start date
2017-11-05
Primary completion
2019-10-01
Enrollment
1645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.